Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Genetics

Alpha-Thalassemia: What Tests Does Your Partner Need?

At a Glance

If you are an alpha-thalassemia carrier planning a pregnancy, your partner should be screened using a complete blood count (CBC), iron studies, and definitive DNA testing. This step-by-step testing identifies if they are also a carrier, helping assess the risk of severe anemia in your baby.

When you know you are an alpha-thalassemia carrier and are planning to have a baby, your partner will need specific blood tests. The goal is to find out if they are also a carrier, which helps determine if your future child might be at risk for a severe form of alpha-thalassemia.

It is highly recommended to complete this screening before you become pregnant, as genetic testing can take several weeks to process. While some modern clinics offer comprehensive direct DNA panels (Expanded Carrier Screening) as a first step, many doctors still use a traditional, step-by-step approach starting with routine blood tests.

Step 1: The Complete Blood Count (CBC)

In a stepwise approach, the first test is a simple, inexpensive Complete Blood Count (CBC) [1]. This looks at the size and characteristics of red blood cells.

Your doctor will specifically look at two numbers:

  • Mean Corpuscular Volume (MCV): This measures the average size of red blood cells. An MCV below 80 fL is a strong indicator that someone might be a thalassemia carrier [1][2].
  • Mean Corpuscular Hemoglobin (MCH): This measures the amount of hemoglobin inside the red blood cells. An MCH below 27 pg is also a sign [1][2].

If both the MCV and MCH are normal, the chances of your partner being a standard alpha-thalassemia carrier are low. However, “silent carriers” (who are missing only one alpha-globin gene) can sometimes have normal CBC results. Depending on your partner’s family history or ethnic background, some doctors may still recommend genetic testing.

Step 2: Iron Studies

If the CBC shows that your partner’s red blood cells are smaller than normal (low MCV) or have less hemoglobin (low MCH), the next step is to check their iron levels [3]. Doctors often order iron tests at the exact same time as the initial CBC.

Because iron deficiency anemia is very common and causes the exact same changes in red blood cells, it is crucial to rule it out [4].

  • If iron levels are low, your partner may need iron supplements. The CBC will be repeated after their iron levels return to normal.
  • If iron levels are normal, but the MCV and MCH remain low, thalassemia is highly suspected [3][4].

Step 3: Hemoglobin Electrophoresis

Alongside the CBC and iron studies, doctors typically order hemoglobin electrophoresis (or Hemoglobin HPLC) [3].

While this test is excellent for identifying carriers of beta-thalassemia or sickle cell trait, it is often completely normal in people who carry alpha-thalassemia [3][5]. Therefore, a “normal” hemoglobin electrophoresis result does not mean your partner is cleared of being an alpha-thalassemia carrier.

Step 4: DNA Genetic Testing

If your partner has small red blood cells (low MCV/MCH), normal iron levels, and a normal hemoglobin electrophoresis, DNA testing is the required next step [3][6].

This is the only definitive way to confirm an alpha-thalassemia diagnosis [6]. A laboratory will analyze your partner’s blood sample to look for specific missing or altered alpha-globin genes [3][7].

Everyone usually inherits four alpha-globin genes (two from each parent).

  • Missing one gene makes you a “silent carrier” with no symptoms.
  • Missing two genes makes you a carrier with mild anemia.
  • The way the two missing genes are arranged matters significantly. If a person is missing two genes on the same chromosome (known as a ‘cis’ deletion), there is a higher mathematical risk to the baby if their partner is also a carrier [8][9].

Knowing the exact genetic mutations for both you and your partner allows a specialist to calculate the exact chances of your baby inheriting a severe condition [8]. These conditions include Hemoglobin H disease (which causes moderate to severe anemia requiring medical care) or Alpha-Thalassemia Major (also known as Hb Bart’s Hydrops Fetalis, a condition that is usually fatal for the fetus before or shortly after birth) [8][9].

What Are Your Family Planning Options?

If DNA testing confirms that both you and your partner are carriers with a risk of passing on a severe form of alpha-thalassemia, you have empowering family planning options. A genetic counselor can discuss strategies such as:

  • In Vitro Fertilization (IVF) with PGT-M: Using IVF to create embryos, and then performing Preimplantation Genetic Testing (PGT-M) to select and transfer only the embryos that do not have the severe disease.
  • Prenatal Testing: Becoming pregnant naturally and undergoing early testing, such as Chorionic Villus Sampling (CVS) or Amniocentesis, to check the baby’s genetic status during pregnancy.

Common questions in this guide

Why does my partner need a complete blood count (CBC) for alpha-thalassemia screening?
A CBC is the first step to check the size (MCV) and hemoglobin content (MCH) of your partner's red blood cells. If these values are lower than normal, it suggests they might be a thalassemia carrier and require further testing.
Why are iron levels checked during thalassemia screening?
Iron deficiency anemia causes the same changes to red blood cells as thalassemia, such as low MCV and MCH. Doctors check iron levels to rule out a simple iron deficiency before proceeding to complex genetic testing.
Can a normal hemoglobin electrophoresis test rule out alpha-thalassemia?
No. While hemoglobin electrophoresis is excellent for detecting beta-thalassemia, it often appears completely normal in people who carry alpha-thalassemia. DNA testing is the only definitive way to rule out or diagnose the condition.
What happens if both my partner and I are alpha-thalassemia carriers?
If DNA testing confirms you are both carriers of specific gene deletions, a genetic counselor can help you explore family planning options. These may include in vitro fertilization (IVF) with preimplantation genetic testing or prenatal testing during a natural pregnancy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What were the specific MCV and MCH values on my partner's CBC?
  2. 2.Since my partner's MCV is low, are we checking their iron levels before ordering genetic tests?
  3. 3.My partner's hemoglobin electrophoresis came back normal; does this definitely rule out alpha-thalassemia, or do we still need DNA testing?
  4. 4.Do you offer Expanded Carrier Screening (DNA testing) from the start, or do you prefer the step-by-step blood test approach?
  5. 5.Based on my genetic mutation and my partner's test results, what are the exact risks for our baby?
  6. 6.If we are both carriers, can you refer us to a genetic counselor to discuss our family planning options?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Accuracy of the model derived from red blood cell indices in predicting α0-thalassemia trait among non-anemic pregnant women.

    Thiamkaew A, Charoenkwan P, Jatavan P, Tongsong T

    Heliyon 2024; (10(20)):e39103 doi:10.1016/j.heliyon.2024.e39103.

    PMID: 39640758
  2. 2

    Molecular and Haematological Characteristics of alpha-Thalassemia Deletions in Yogyakarta Special Region, Indonesia.

    Husna N, Handayani NSN

    Reports of biochemistry & molecular biology 2021; (10(3)):346-353 doi:10.52547/rbmb.10.3.346.

    PMID: 34981010
  3. 3

    Update in Laboratory Diagnosis of Thalassemia.

    Munkongdee T, Chen P, Winichagoon P, et al.

    Frontiers in molecular biosciences 2020; (7()):74 doi:10.3389/fmolb.2020.00074.

    PMID: 32671092
  4. 4

    Enhancing thalassemia carrier detection: Advancing genetic screening strategies in prenatal care.

    Chen HY, Lin YL, Su YN, et al.

    Journal of the Formosan Medical Association = Taiwan yi zhi 2025; doi:10.1016/j.jfma.2025.06.028.

    PMID: 40544106
  5. 5

    Molecular Detection of Alpha Thalassemia: A Review of Prevalent Techniques.

    Vijian D, Wan Ab Rahman WS, Ponnuraj KT, et al.

    Medeniyet medical journal 2021; (36(3)):257-269 doi:10.5222/MMJ.2021.14603.

    PMID: 34915685
  6. 6

    Third-generation sequencing identified a novel complex variant in a patient with rare alpha-thalassemia.

    Zhou C, Du Y, Zhang H, et al.

    BMC pediatrics 2024; (24(1)):330 doi:10.1186/s12887-024-04811-1.

    PMID: 38741052
  7. 7

    A rare hemoglobinopathy duo: Hb Adana×Hb SEA in a 1-year-old patient - a case report and a brief literature review.

    Faheem Y, Baroudi MM, Emad Al Saddik S, et al.

    Annals of medicine and surgery (2012) 2024; (86(6)):3730-3735 doi:10.1097/MS9.0000000000002101.

    PMID: 38846854
  8. 8

    Analysis of Hematological Parameters in Relation to Genotypes in 497 Patients with Hemoglobin H Disease.

    Lan L, Zheng Z, Wu H

    International journal of general medicine 2025; (18()):7547-7557 doi:10.2147/IJGM.S567328.

    PMID: 41424969
  9. 9

    [Clinical practice guidelines for alpha-thalassemia].

    Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association , Shang X, Zhang X, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(3)):235-242 doi:10.3760/cma.j.issn.1003-9406.2020.03.003.

    PMID: 32128738

This page explains partner screening for alpha-thalassemia for educational purposes only. Always consult a genetic counselor or your doctor to discuss your specific test results and family planning options.

Get notified when new evidence is published on Alpha-thalassemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.